{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:50:43Z","timestamp":1780332643563,"version":"3.54.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":3565,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1093\/bja\/aem406","type":"journal-article","created":{"date-parts":[[2008,2,14]],"date-time":"2008-02-14T04:37:56Z","timestamp":1202963876000},"page":"288-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Statins and sepsis"],"prefix":"10.1016","volume":"100","author":[{"given":"F","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Linhartova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.McD.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Thickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aem406_bib1","unstructured":"Best treatment, clinical evidence for patients from the BMJ. 2006"},{"key":"10.1093\/bja\/aem406_bib2","unstructured":"Search the Medscape Drug Reference. 2006"},{"key":"10.1093\/bja\/aem406_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"10.1093\/bja\/aem406_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0037-1614576","article-title":"Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit model","volume":"81","author":"Alfon","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1093\/bja\/aem406_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.CCM.0000253397.42079.D5","article-title":"The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases","volume":"35","author":"Almog","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1378\/chest.124.2.740","article-title":"Statins, inflammation, and sepsis: hypothesis [Editorial]","volume":"124","author":"Almog","year":"2003","journal-title":"Chest"},{"key":"10.1093\/bja\/aem406_bib8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.CIR.0000138932.17956.F1","article-title":"Prior statin therapy is associated with a decreased rate of severe sepsis [Article]","volume":"110","author":"Almog","year":"2004","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib9","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(24)39169-4","article-title":"Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis","volume":"294","author":"Ando","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1093\/bja\/aem406_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00134-006-0512-z","article-title":"Year in review in intensive care medicine, 2006. II Infections and sepsis, haemodynamics, elderly, invasive and noninvasive mechanical ventilation, weaning, ARDS","volume":"33","author":"Andrews","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1093\/bja\/aem406_bib11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aem406_bib12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"10.1093\/bja\/aem406_bib14","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.ATV.0000163840.63685.0c","article-title":"Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins","volume":"25","author":"Arnaud","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/bja\/aem406_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/cc4900","article-title":"Recently published papers: Sugar, soap and statins'an unlikely recipe for the critically ill","volume":"10","author":"Bacon","year":"2006","journal-title":"Crit Care"},{"key":"10.1093\/bja\/aem406_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aem406_bib17","series-title":"British National Formulary","article-title":"2.12 Lipid-regulating drugs","year":"2006"},{"key":"10.1093\/bja\/aem406_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/01.ATV.20.2.556","article-title":"HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells","volume":"20","author":"Bourcier","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/bja\/aem406_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archinte.1991.00400010067008","article-title":"Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia","volume":"151","author":"Bradford","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1093\/bja\/aem406_bib20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.CCM.0000201407.89977.EA","article-title":"Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery","volume":"34","author":"Chello","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1345\/aph.1H550","article-title":"The role of statin therapy in sepsis","volume":"41","author":"Chua","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1093\/bja\/aem406_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.clpt.2005.07.003","article-title":"Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers","volume":"78","author":"Chung","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/bja\/aem406_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/j.1552-4604.1996.tb04224.x","article-title":"Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening","volume":"36","author":"Cilla","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1093\/bja\/aem406_bib24","first-page":"3527","article-title":"Endothelial cells in physiology and in the pathophysiology of vascular disorders","volume":"91","author":"Cines","year":"1998","journal-title":"Blood"},{"key":"10.1093\/bja\/aem406_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"10.1093\/bja\/aem406_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0037-1613151","article-title":"Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study","volume":"88","author":"Cortellaro","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1093\/bja\/aem406_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3949\/ccjm.55.1.93","article-title":"HMG-CoA reductase inhibitors. A new approach to the management of hypercholesterolemia","volume":"55","author":"Cressman","year":"1988","journal-title":"Cleve Clin J Med"},{"key":"10.1093\/bja\/aem406_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/cs0860359","article-title":"Role of the endothelium in modulating the vascular response to sepsis","volume":"86","author":"Curzen","year":"1994","journal-title":"Clin Sci (Lond)"},{"key":"10.1093\/bja\/aem406_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/13543784.11.1.125","article-title":"Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia","volume":"11","author":"Davidson","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1093\/bja\/aem406_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4414\/smw.2001.05883","article-title":"CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia","volume":"131","author":"de Werra","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"10.1093\/bja\/aem406_bib31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/clind\/16.6.792","article-title":"Severe invasive group A streptococcal infections in Ontario, Canada: 1987\u20131991","volume":"16","author":"Demers","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1093\/bja\/aem406_bib32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.ATV.0000043456.48735.20","article-title":"HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells [Miscellaneous Article]","volume":"23","author":"Dichtl","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/bja\/aem406_bib33","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/hq0801.094222","article-title":"In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products","volume":"21","author":"Diomede","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/bja\/aem406_bib34","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1197\/j.aem.2007.03.1216","article-title":"Statin therapy in patients with sepsis","volume":"14","author":"Donnino","year":"2007","journal-title":"Acad Emerg Med"},{"key":"10.1093\/bja\/aem406_bib35","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1203\/00006450-200212000-00018","article-title":"sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome","volume":"52","author":"Doughty","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1093\/bja\/aem406_bib36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archsurg.1994.01420340045008","article-title":"Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial","volume":"129","author":"Dries","year":"1994","journal-title":"Arch Surg"},{"key":"10.1093\/bja\/aem406_bib37","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/bmj.318.7198.1606","article-title":"ABC of intensive care: organ dysfunction","volume":"318","author":"Evans","year":"1999","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aem406_bib38","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(01)06489-3","article-title":"Learning from the cerivastatin experience","volume":"358","author":"Farmer","year":"2001","journal-title":"Lancet"},{"key":"10.1093\/bja\/aem406_bib39","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1378\/chest.06-1997","article-title":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins","volume":"131","author":"Frost","year":"2007","journal-title":"Chest"},{"key":"10.1093\/bja\/aem406_bib40","first-page":"205","article-title":"Withdrawal of cerivastatin from the world market","volume":"2","author":"Furberg","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"10.1093\/bja\/aem406_bib41","first-page":"1133","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"2","author":"Gattone","year":"2001","journal-title":"Ital Heart J Suppl"},{"key":"10.1093\/bja\/aem406_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/10.shk.0000115756.74059.ce","article-title":"Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats [Article]","volume":"21","author":"Giusti-Paiva","year":"2004","journal-title":"Shock"},{"key":"10.1093\/bja\/aem406_bib43","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/00003246-200009001-00002","article-title":"Pathophysiologic basis of sepsis: considerations for future strategies of intervention","volume":"28","author":"Glauser","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","article-title":"Statins and the vascular endothelial inflammatory response","volume":"28","author":"Greenwood","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1093\/bja\/aem406_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1093\/bja\/aem406_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02684000","article-title":"Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes","volume":"51","author":"Grip","year":"2002","journal-title":"Inflamm Res"},{"key":"10.1093\/bja\/aem406_bib47","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.297.13.1455","article-title":"Statin use and hospitalization for sepsis in patients with chronic kidney disease","volume":"297","author":"Gupta","year":"2007","journal-title":"JAMA"},{"key":"10.1093\/bja\/aem406_bib48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(06)68041-0","article-title":"Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis","volume":"367","author":"Hackam","year":"2006","journal-title":"Lancet"},{"key":"10.1093\/bja\/aem406_bib49","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/01.ATV.18.10.1643","article-title":"Combination of fosinopril and pravastatin decreases platelet response to thrombin receptor agonist in monkeys","volume":"18","author":"Hale","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/bja\/aem406_bib50","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1097\/00003246-200205001-00009","article-title":"Endothelial cell apoptosis in sepsis","volume":"30","author":"Hotchkiss","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib51","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/106002809502907-818","article-title":"Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia","volume":"29","author":"Hsu","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1093\/bja\/aem406_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0049-3848(99)00037-7","article-title":"Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor","volume":"95","author":"Huhle","year":"1999","journal-title":"Thromb Res"},{"key":"10.1093\/bja\/aem406_bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0889-8529(18)30329-3","article-title":"Drug treatment of dyslipoproteinemia","volume":"19","author":"Hunninghake","year":"1990","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1093\/bja\/aem406_bib54","author":"IHI"},{"key":"10.1093\/bja\/aem406_bib55","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0024-3205(00)00680-9","volume":"67","author":"Inoue","year":"2000","journal-title":"Life Sci"},{"key":"10.1093\/bja\/aem406_bib56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0735-1097(98)00514-2","article-title":"Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions","volume":"33","author":"Kaesemeyer","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/bja\/aem406_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1357-4310(98)01430-0","article-title":"The molecular pathogenesis of endotoxic shock and organ failure","volume":"5","author":"Karima","year":"1999","journal-title":"Mol Med Today"},{"key":"10.1093\/bja\/aem406_bib58","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1182\/blood-2003-11-3791","article-title":"Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro","volume":"103","author":"Kleemann","year":"2004","journal-title":"Blood"},{"key":"10.1093\/bja\/aem406_bib59","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.101.15.1760","article-title":"Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae","volume":"101","author":"Kothe","year":"2000","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib60","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2165\/00003495-200363170-00005","article-title":"Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes [Review]","volume":"63","author":"Krysiak","year":"2003","journal-title":"Drugs"},{"key":"10.1093\/bja\/aem406_bib61","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/79510","article-title":"The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals","volume":"6","author":"Kureishi","year":"2000","journal-title":"Nat Med"},{"key":"10.1093\/bja\/aem406_bib62","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1161\/01.CIR.92.11.3172","article-title":"Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction","volume":"92","author":"Lacoste","year":"1995","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib63","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aem406_bib64","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1161\/01.CIR.102.25.3104","article-title":"Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription","volume":"102","author":"Laufs","year":"2000","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI9639","article-title":"Neuroprotection mediated by changes in the endothelial actin cytoskeleton","volume":"106","author":"Laufs","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1093\/bja\/aem406_bib66","doi-asserted-by":"crossref","first-page":"31725","DOI":"10.1074\/jbc.272.50.31725","article-title":"Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase","volume":"272","author":"Laufs","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1093\/bja\/aem406_bib67","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/01.STR.31.10.2442","article-title":"Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice","volume":"31","author":"Laufs","year":"2000","journal-title":"Stroke"},{"key":"10.1093\/bja\/aem406_bib68","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib69","doi-asserted-by":"crossref","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","article-title":"Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase","volume":"273","author":"Laufs","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1093\/bja\/aem406_bib70","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/01.CCM.0000261883.16943.4B","article-title":"Sepsis since the discovery of Toll-like receptors: disease concepts and therapeutic opportunities","volume":"35","author":"Leaver","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib71","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1093\/bja\/aem406_bib72","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1172\/JCI200113131","article-title":"HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells","volume":"108","author":"Llevadot","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1093\/bja\/aem406_bib73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI9419","article-title":"Acute modulation of endothelial Akt\/PKB activity alters nitric oxide-dependent vasomotor activity in vivo","volume":"106","author":"Luo","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1093\/bja\/aem406_bib74","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ahj.2004.07.041","article-title":"Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study [Article]","volume":"149","author":"Macin","year":"2005","journal-title":"Am Heart J"},{"key":"10.1093\/bja\/aem406_bib75","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bmj.38992.565972.7C","article-title":"Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study","volume":"333","author":"Majumdar","year":"2006","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aem406_bib76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib77","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1084","article-title":"Such stuff as dreams are made on: mediator-directed therapy in sepsis","volume":"2","author":"Marshall","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1093\/bja\/aem406_bib78","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.4049\/jimmunol.163.4.2217","article-title":"Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS)","volume":"163","author":"Matute-Bello","year":"1999","journal-title":"J Immunol"},{"key":"10.1093\/bja\/aem406_bib79","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF01696223","article-title":"Effects of long-term treatment with lovastatin on the clotting system and blood platelets","volume":"64","author":"Mayer","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1093\/bja\/aem406_bib80","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"10.1093\/bja\/aem406_bib81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/bja\/ael358","article-title":"Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide","volume":"98","author":"McGown","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aem406_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00134-005-2860-5","article-title":"Statins: the next step in adjuvant therapy for sepsis?","volume":"32","author":"Mekontso-Dessap","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1093\/bja\/aem406_bib83","first-page":"309","article-title":"Statins in the intensive care unit","volume":"12","author":"Merx","year":"2006","journal-title":"Curr Opin Crit Care"},{"key":"10.1093\/bja\/aem406_bib84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCULATIONAHA.104.502195","article-title":"Statin treatment after onset of sepsis in a murine model improves survival [Article]","volume":"112","author":"Merx","year":"2005","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib85","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.CIR.0000129774.09737.5B","article-title":"HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis [Report]","volume":"109","author":"Merx","year":"2004","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib86","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bmj.332.7554.1344","article-title":"Switching statins","volume":"332","author":"Moon","year":"2006","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aem406_bib87","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-5273(00)00439-3","article-title":"Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia","volume":"77","author":"Musial","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1093\/bja\/aem406_bib88","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1164\/ajrccm.163.1.9912036","article-title":"Circulating endothelial cells in patients with septic shock","volume":"163","author":"Mutunga","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib89","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2005.12.022","article-title":"Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo","volume":"189","author":"Niessner","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1093\/bja\/aem406_bib90","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.ATV.15.2.247","article-title":"Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia","volume":"15","author":"Notarbartolo","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/bja\/aem406_bib91","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/cc3972","article-title":"Do statins have a role in preventing or treating sepsis?","volume":"10","author":"Novack","year":"2006","journal-title":"Crit Care"},{"key":"10.1093\/bja\/aem406_bib92","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.surg.2006.08.011","article-title":"Cytochrome P450 activity mirrors nitric oxide levels in postoperative sepsis: predictive indicators of lethal outcome","volume":"141","author":"Novotny","year":"2007","journal-title":"Surgery"},{"key":"10.1093\/bja\/aem406_bib93","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/01.CCM.0000085141.75513.2B","article-title":"Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland [Article]","volume":"31","author":"Padkin","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib94","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/j.1552-4604.1990.tb01856.x","article-title":"Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin","volume":"30","author":"Pan","year":"1990","journal-title":"J Clin Pharmacol"},{"key":"10.1093\/bja\/aem406_bib95","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","article-title":"ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins","volume":"106","author":"Pasternak","year":"2002","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00002018-199614010-00003","article-title":"Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal","volume":"14","author":"Pedersen","year":"1996","journal-title":"Drug Saf"},{"key":"10.1093\/bja\/aem406_bib97","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.1990.03450010075034","article-title":"Myopathy and rhabdomyolysis associated with lovastatin\u2013gemfibrozil combination therapy","volume":"264","author":"Pierce","year":"1990","journal-title":"JAMA"},{"key":"10.1093\/bja\/aem406_bib98","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1161\/01.CIR.0000147774.90396.ED","article-title":"Simvastatin prevents vascular hyporeactivity during inflammation [Article]","volume":"110","author":"Pleiner","year":"2004","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib99","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/01.CIR.0000034048.38910.91","article-title":"Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin","volume":"106","author":"Pruefer","year":"2002","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib100","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2353\/ajpath.2007.060872","article-title":"Pathophysiology of sepsis","volume":"170","author":"Remick","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1093\/bja\/aem406_bib101","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aem406_bib102","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.103.9.1191","article-title":"Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib103","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib104","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aem406_bib105","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/labinvest.3780115","article-title":"Inhibition of monocyte chemotactic protein-1 synthesis by statins","volume":"80","author":"Romano","year":"2000","journal-title":"Lab Invest"},{"key":"10.1093\/bja\/aem406_bib106","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/14779072.1.4.495","article-title":"Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia","volume":"1","author":"Rosenson","year":"2003","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1093\/bja\/aem406_bib107","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1164\/rccm.200606-777PP","article-title":"Targeting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary disease","volume":"175","author":"Sabroe","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib108","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1093\/bja\/aem406_bib109","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1592\/phco.27.3.325","article-title":"Statins and the risk of pneumonia: a population-based, nested case-control study","volume":"27","author":"Schlienger","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1093\/bja\/aem406_bib110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001721-200309000-00010","article-title":"Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation","volume":"14","author":"Shi","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1093\/bja\/aem406_bib111","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2006.03.003","article-title":"Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug\u2013drug interactions and interindividual differences in transporter and metabolic enzyme functions","volume":"112","author":"Shitara","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1093\/bja\/aem406_bib112","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/01.CIR.0000158665.27783.0C","article-title":"Simvastatin blunts endotoxin-induced tissue factor in vivo [Article]","volume":"111","author":"Steiner","year":"2005","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib113","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1473-3099(06)70439-X","article-title":"Statins: panacea for sepsis?","volume":"6","author":"Terblanche","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1093\/bja\/aem406_bib114","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jlb.55.6.749","article-title":"Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells","volume":"55","author":"Terkeltaub","year":"1994","journal-title":"J Leukoc Biol"},{"key":"10.1093\/bja\/aem406_bib115","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm.164.9.2011071","article-title":"Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome","volume":"164","author":"Thickett","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/bja\/aem406_bib116","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/j.1552-4604.1992.tb05773.x","article-title":"Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers","volume":"32","author":"Tse","year":"1992","journal-title":"J Clin Pharmacol"},{"key":"10.1093\/bja\/aem406_bib117","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/CMR.16.3.379-414.2003","article-title":"Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock","volume":"16","author":"Van Amersfoort","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1093\/bja\/aem406_bib118","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2006.062885","article-title":"Statin therapy and reduced risk of pneumonia in patients with diabetes","author":"van de Garde","year":"2006","journal-title":"Thorax"},{"key":"10.1093\/bja\/aem406_bib119","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in the critically ill patients","volume":"345","author":"Van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aem406_bib120","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/01.CIR.0000139312.10076.BA","article-title":"Update on statins: 2003","volume":"110","author":"Vaughan","year":"2004","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","article-title":"The evolving role of statins in the management of atherosclerosis","volume":"35","author":"Vaughan","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/bja\/aem406_bib122","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mca.0000131572.14521.8a","article-title":"Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells [Review]","volume":"15","author":"Walter","year":"2004","journal-title":"Coron Artery Dis"},{"key":"10.1093\/bja\/aem406_bib123","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.CIR.0000160382.01347.FF","article-title":"Should treatment of sepsis include statins? [Editorial]","volume":"111","author":"Warnholtz","year":"2005","journal-title":"Circulation"},{"key":"10.1093\/bja\/aem406_bib124","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0735-1097(97)00324-0","article-title":"HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia","volume":"30","author":"Weber","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/bja\/aem406_bib125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"},{"key":"10.1093\/bja\/aem406_bib126","first-page":"255","article-title":"Molecular biology on the ICU. From understanding to treating sepsis","volume":"72","author":"Winning","year":"2006","journal-title":"Minerva Anestesiol"},{"key":"10.1093\/bja\/aem406_bib127","first-page":"92","article-title":"Nuclear matrix protein, tumor necrosis factor-alpha, and nitrite\/nitrate levels in patients with multiple organ dysfunction syndrome","volume":"100","author":"Yamada","year":"1998","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1093\/bja\/aem406_bib128","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/sj.ki.5000300","article-title":"Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects","volume":"69","author":"Yasuda","year":"2006","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aem406_bib129","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/hq0701.092143","article-title":"Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism","volume":"21","author":"Yoshida","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/bja\/aem406_bib130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5551\/jat.13.108","article-title":"Efficacy of a low dose of pitavastatin compared with atorvastatin in primary hyperlipidemia: results of a 12-week, open label study","volume":"13","author":"Yoshitomi","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"10.1093\/bja\/aem406_bib131","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.HYP.0000136395.06810.cf","article-title":"Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of enos and oxidant stress [Article]","volume":"44","author":"Zhou","year":"2004","journal-title":"Hypertension"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217346494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217346494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/100\/3\/288\/664837\/aem406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:48:08Z","timestamp":1757789288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217346494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0007091217346494"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aem406","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1119045.575180","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1119045.576344","asserted-by":"object"}]},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins and sepsis","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/bja\/aem406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}